Cell surface lipids hide molecular patterns that infection-killing cells might recognize as dangerous.
Currently browsing: Department of Microbiology
Three University of Washington faculty members are among those honored with a grant from the National Institutes of Health’s High Risk-High Reward program.
A combination of interferon-alpha 2b and ribavirin, drugs routinely given for hepatitis C, may be an effective treatment for the coronovirus that causes this new disease.
Funded by the NIH at $15 million over five years, the lab will be a national resource to evaluate candidate vaccines from studies around the country.